C. Fraser-Browne

发表

Contour variation is a primary source of error when delivering post prostatectomy radiotherapy: Results of the Trans‐Tasman Radiation Oncology Group 08.03 Radiotherapy Adjuvant Versus Early Salvage (RAVES) benchmarking exercise

Annette Haworth, Michael G Jameson, Lois C Holloway, 2019, Journal of medical imaging and radiation oncology.

Optimizing Radiation Therapy Quality Assurance in Clinical Trials: A TROG 08.03 RAVES Substudy.

A. Kneebone, Colin Tang, K. Wiltshire, 2015, International journal of radiation oncology, biology, physics.

Phase 3 trial of domiciliary humidification to mitigate acute mucosal toxicity during radiation therapy for head-and-neck cancer: first report of Trans Tasman Radiation Oncology Group (TROG) 07.03 RadioHUM study.

M. King, Colin Tang, M. Poulsen, 2014, International journal of radiation oncology, biology, physics.

A Phase III Multi-Centre Randomised Trial comparing adjuvant versus early salvage Radiotherapy following a Radical Prostatectomy: Results of the TROG 08.03 and ANZUP “RAVES” Trial

R. Fisher, H. Woo, M. Frydenberg, 2019, International Journal of Radiation Oncology*Biology*Physics.

Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data

M. Sydes, C. Parker, M. Parmar, 2020, The Lancet.

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial.

R. Fisher, H. Woo, M. Frydenberg, 2020, The Lancet Oncology.

Early Outcome of a Phase I/II Clinical Trial (NCT03538899) of Gene-Corrected Autologous CD34+ Hematopoietic Cells and Low-Exposure Busulfan in Newly Diagnosed Patients with Artemis-Deficient Severe Combined Immunodeficiency (ART-SCID)

J. Puck, R. McIvor, H. Malech, 2020 .

A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high‐risk features: background and rationale of the Radiotherapy – Adjuvant Versus Early Salvage (RAVES) trial

R. Fisher, H. Woo, M. Frydenberg, 2014, BJU international.

Azacitidine Administration Following Hematopoietic Stem Cell Transplantation Is Safe and Feasible in Children with Acute Leukemia

J. Willert, C. Dvorak, C. Fraser-Browne, 2016 .

Do screening trial recruitment logs accurately reflect the eligibility criteria of a given clinical trial? Early lessons from the RAVES 0803 trial.

H. Woo, A. Kneebone, S. Turner, 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

Humidification mitigates acute mucosal toxicity during radiotherapy when factoring volumetric parameters. Trans Tasman Radiation Oncology Group (TROG) RadioHUM 07.03 substudy.

A. Raith, G. Sasso, J. Simpson, 2017, Oral oncology.

Lentiviral Gene Therapy for Artemis-Deficient SCID.

J. Puck, J. Hilton, H. Malech, 2022, The New England journal of medicine.

Adjuvant or salvage radiotherapy for the treatment of localised prostate cancer? A prospectively planned aggregate data meta-analysis

M. Sydes, C. Parker, S. Nénan, 2019, Annals of Oncology.